CONMED Corp Files 8-K on Financials
Ticker: CNMD · Form: 8-K · Filed: Feb 5, 2025 · CIK: 816956
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: CNMD
TL;DR
CONMED filed an 8-K on Feb 5, 2025, detailing financial results and condition.
AI Summary
CONMED Corporation filed an 8-K on February 5, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details CONMED's corporate information, including its principal executive offices in Largo, Florida, and its IRS Employer Identification Number.
Why It Matters
This filing provides investors with crucial updates on CONMED Corporation's financial performance and condition, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) that does not appear to contain any immediately alarming or significant new information.
Key Players & Entities
- CONMED Corporation (company) — Registrant
- 11311 Concept Blvd Largo, Florida 33773 (location) — Principal executive offices
- February 5, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this Form 8-K filing for CONMED Corporation?
The primary purpose of this Form 8-K filing is to report on CONMED Corporation's Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on February 5, 2025.
What is CONMED Corporation's principal executive office address?
CONMED Corporation's principal executive office is located at 11311 Concept Blvd, Largo, Florida 33773.
What is CONMED Corporation's IRS Employer Identification Number?
CONMED Corporation's IRS Employer Identification Number is 16-0977505.
In which state was CONMED Corporation incorporated?
CONMED Corporation was incorporated in Delaware.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-02-05 16:15:50
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value CNMD NYSE Indicate by che
Filing Documents
- form8k-33496_cnmd.htm (8-K) — 24KB
- ex99-1.htm (EX-99.1) — 277KB
- image_001.jpg (GRAPHIC) — 4KB
- 0001174947-25-000129.txt ( ) — 494KB
- cnmd-20250205.xsd (EX-101.SCH) — 3KB
- cnmd-20250205_lab.xml (EX-101.LAB) — 33KB
- cnmd-20250205_pre.xml (EX-101.PRE) — 22KB
- form8k-33496_cnmd_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 5, 2025, CONMED Corporation issued a press release announcing financial results for the fourth quarter ended December 31, 2024. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K that is furnished under "Item 2.02. Results of Operations and Financial Condition" and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibits are included herewith: Exhibit No. Description of Exhibit 99.1 Press Release dated February 5, 2025, issued by CONMED Corporation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 5, 2025 CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Name: Todd W. Garner Title: Executive Vice President, Finance & Chief Financial Officer